From masshightech.com
()
Advocacy and Autism Spectrum Disorders
Mobilizing people and resources behind helping individuals with Autism Spectrum Disorders, a growing phenomenon where one in every 150 births in the United States are diagnosed with ASD by the time they're 3.
Seaside Therapeutics LLC has begun a Phase 1 clinical trial for STX-107, a drug target that is designed for the treatment of Fragile X Syndrome. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.
Comments
Be the first to leave a comment!
People in Pictures
Top Wellness Articles
 |
Twilight’s Christian Serratos Gets Naked For PETA
Serratos poses naked for the 'I'd Rather Go Naked Than Wear Fur' campaign.
|
 |
30 Greenest Celebs
See which celebrities are giving back to their Mother Earth.
|
 |
Injured Celebrities
Check out stars who've taken a few blows.
|
